ZA823673B - Bovine mastitis vaccine and method for detecting efficacy thereof - Google Patents

Bovine mastitis vaccine and method for detecting efficacy thereof

Info

Publication number
ZA823673B
ZA823673B ZA823673A ZA823673A ZA823673B ZA 823673 B ZA823673 B ZA 823673B ZA 823673 A ZA823673 A ZA 823673A ZA 823673 A ZA823673 A ZA 823673A ZA 823673 B ZA823673 B ZA 823673B
Authority
ZA
South Africa
Prior art keywords
bovine mastitis
mastitis vaccine
detecting efficacy
efficacy
detecting
Prior art date
Application number
ZA823673A
Other languages
English (en)
Inventor
Neil L Norcross
Johanna P Opdebeeck
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of ZA823673B publication Critical patent/ZA823673B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA823673A 1981-05-20 1982-05-26 Bovine mastitis vaccine and method for detecting efficacy thereof ZA823673B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/265,287 US4425330A (en) 1981-05-20 1981-05-20 Bovine mastitis vaccine and method for detecting efficacy thereof

Publications (1)

Publication Number Publication Date
ZA823673B true ZA823673B (en) 1984-01-25

Family

ID=23009830

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA823673A ZA823673B (en) 1981-05-20 1982-05-26 Bovine mastitis vaccine and method for detecting efficacy thereof

Country Status (5)

Country Link
US (1) US4425330A (fr)
EP (1) EP0094997A1 (fr)
AU (1) AU561890B2 (fr)
CA (1) CA1200487A (fr)
ZA (1) ZA823673B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI68262C (fi) * 1982-12-17 1985-08-12 Labsystems Oy Foerfarande foer konstatering av juverinflammation
US5198214A (en) * 1983-08-31 1993-03-30 Stolle Research & Development Corporation Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
US4762712A (en) * 1983-08-31 1988-08-09 Stolle Research & Development Corporation Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
US5189015A (en) * 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
IN164864B (fr) * 1985-05-13 1989-06-24 Commw Scient Ind Res Org
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US5132210A (en) * 1986-12-02 1992-07-21 Proscience Corporation Diagnostic test for staphylococcal mastitis
US4849341A (en) * 1986-12-02 1989-07-18 Proscience Corporation Diagnostic test for Staphylococcal mastitis in cattle
US5198215A (en) * 1987-06-22 1993-03-30 Noordzee Laboratorium N.V. Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
NL8701451A (nl) * 1987-06-22 1989-01-16 Noordzee Lab N V Preparaat voor de bestrijding van mastitis bij herkauwers, werkwijze voor de bereiding daarvan en werkwijze voor het behandelen van herkauwers.
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
GB9201013D0 (en) * 1992-01-17 1992-03-11 Animal Health Inst Vaccines
ES2051621B1 (es) * 1992-02-04 1995-01-16 Consejo Superior Investigacion Procedimiento de obtencion de vacuna frente a estafilococos.
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
IL107103A (en) * 1992-09-24 2001-03-19 Brigham & Womens Hospital Multivalent vaccine based on conjugated molecule comprising a capsular polysaccharide linked to a protein and a method for the preparation thereof
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
JPH0840932A (ja) * 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
IL122829A (en) * 1997-12-31 2000-06-29 Maabarot Products Ltd Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
DE69933707T2 (de) * 1999-08-25 2007-08-23 Accuplex, L.L.C. Serum amyloid a als marker für entzündungsreaktion, milchqualität und die anwesenheit von kolostrum in milch
US6509444B1 (en) 1999-10-22 2003-01-21 The Board Of Regents Of The University Of Nebraska Serum amyloid a isoform from colostrum
JP2003512839A (ja) * 1999-10-22 2003-04-08 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ 初乳由来の血清アミロイドａアイソフォーム
AU782508B2 (en) * 1999-11-08 2005-08-04 Biomune Vaccines for mycoplasma bovis and methods of use
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
ATE439372T1 (de) * 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
US7118756B2 (en) * 2000-12-28 2006-10-10 Wyeth Recombinant protective protein from Streptococcus pneumoniae
GB0108332D0 (en) * 2001-04-03 2001-05-23 Univ Durham Lectin directed prodrug delivery system
CA2808598A1 (fr) * 2001-08-02 2003-02-13 University Of Sheffield Polypeptides antigenes
AU2002364507A1 (en) * 2001-11-21 2003-06-10 Board Of Regents Of The University Of Nebraska Mammary-associated serum amyloid a3 promoter sequences and uses for same
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
US7368546B2 (en) * 2003-01-21 2008-05-06 The Board Of Regents Of The University Of Nebraska Human SAA3 nucleic acid molecule, protein, and methods of use for same
US7204993B2 (en) * 2004-03-18 2007-04-17 The United States Of America As Represented By The Secretary Of Agriculture Streptococcus agalactiae vaccine
CN101107010A (zh) 2004-11-01 2008-01-16 布里格海姆妇女医院公司 经修饰的链球菌多糖及其用途
EP2059807B1 (fr) * 2006-08-17 2013-02-20 The UAB Research Foundation Diagnostic d'une pneumonie à pneumocoques
ES2678143T3 (es) 2010-01-19 2018-08-09 President And Fellows Of Harvard College Opsonina obtenida por ingeniería genética para la detección y el tratamiento de microorganismos patógenos
EP2734843A2 (fr) 2011-07-18 2014-05-28 President and Fellows of Harvard College Molécules manipulées ciblant un microbe et leurs utilisations
EP2976642A4 (fr) 2013-03-15 2016-09-21 Harvard College Procédés et compositions pour améliorer la détection et/ou la capture d'une entité cible
US9988617B2 (en) 2013-05-21 2018-06-05 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3546474B1 (fr) 2013-12-18 2021-07-07 President and Fellows of Harvard College Capture/détection de bactéries gram positif à l'aide de crp
CN108289928B (zh) 2015-08-06 2024-09-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途
CN106749651B (zh) * 2016-12-20 2020-11-10 天津瑞普生物技术股份有限公司 一种无乳链球菌型特异性抗血清的制备方法
CN113207913B (zh) * 2021-04-30 2022-06-14 石河子大学 一种奶牛乳房炎生物消毒剂制备与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182555A (en) * 1967-10-16 1970-02-25 Saphar Lab Ltd An Anti-Mastitis Vaccine
JPS5452794A (en) 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
US4207414A (en) 1978-08-16 1980-06-10 President And Fellows Of Harvard College Polysaccharide antigens
US4327082A (en) * 1979-07-12 1982-04-27 Adcock-Ingram Laboratories Limited Mastitis vaccination
IE51174B1 (en) * 1980-04-14 1986-10-29 Merck & Co Inc Group b streptococcal capsular polysaccharides

Also Published As

Publication number Publication date
CA1200487A (fr) 1986-02-11
AU8414882A (en) 1982-12-02
EP0094997A1 (fr) 1983-11-30
AU561890B2 (en) 1987-05-21
US4425330A (en) 1984-01-10

Similar Documents

Publication Publication Date Title
GB8729433D0 (en) Handling method & device
AU561890B2 (en) Polyvalent bovine mastitis vaccine
DE3369465D1 (en) Bone-equivalent and method for preparation thereof
DE3175732D1 (en) Anastomotic device and method
JPS57177627A (en) Improved hydroponec growth system and method
IL90325A (en) Method and apparatus for automatic milking
JPS57176129A (en) Method and device for manufacturing preparatory shape for bottle
DE3274618D1 (en) Method and apparatus for forming bales
JPS57192553A (en) Aseptic bandage and method
DE3273714D1 (en) Method and means for repelling animals
GB2117214B (en) Crop engaging device and method
GB2100963B (en) Harvesting method and machine
GB2106163B (en) Well completion and testing system and method
JPS57138897A (en) Method and device for controlling chopper
DE3162663D1 (en) Means and method for detecting rotating stall
HUT35918A (en) Method for milking and device for carrying out the method
IL84672A0 (en) Method for detecting mastitis
JPS57134260A (en) Casting method and its device
ZA823057B (en) Method and agents for arresting fulminating infection
EP0227335A3 (en) Method and means for detecting infection in animals
IE821363L (en) Device for introducing nutrients and/or therapeutic¹materials into ruminant animals
JPS57153826A (en) Method and device for forming package
EP0158489A3 (en) Handling apparatus & method
EP0184266A3 (en) Device and method for keeping animals
GB2114746B (en) Gaging system and method